WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

International application published with international search report

Frontiers The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies

US5624821A - Antibodies with altered effector functions - Google Patents

US20220041712A1 - Anti-claudin 18 antibodies and methods of use thereof - Google Patents

WO2020135674A1 - Claudin18.2 binding moieties and uses thereof - Google Patents

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

Pharmaceutics, Free Full-Text

WO2021132427A1 - Anti-cdcp1 antibody - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

WO2021238831A1 - Anti-cldn18.2 antibodies and diagnostic uses thereof - Google Patents

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells

WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents